Description
The global market for Radioisotopes is estimated to be valued as $ 8.55 billion in 2014 and is expected to reach $ 15.37 billion by the end of 2019 . During this period of forecast the market is expected to grow at a CAGR of 12.45 %.
Request a sample of this report @ http :// www . orbisresearch . com / contacts / request-sample / 219737 .
Major driving factors for the growth of the market are increasing demand of SPECT analysis in radiopharmaceuticals , development of better instruments , newer computer based procedures for image analysis and display , new 99mTc labeled agents for visualizing biologically significant events , increasing demand of PET analysis in radiopharmaceuticals , increasing use in clinical applications to study psychiatric disorders . Integration of X ray tomography ( CT ) into SPECT has recently emerged as a brilliant diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market . . However , some of the major constrains for the market are shorter half- life of radioisotopes , high capital investment , regulatory guidelines and reimbursement issues .
SPECT radioisotopes chemical form of thallous chloride has been the principle tracer used in myocardial perfusion imaging . Technetium-99m is the major radioisotope used in SPECT . Generally technetium is produced in technetium generators . Tl-201 is used in myocardial perfusion studies , In-111 is used in prostate cancer , and Ga-67 is used in lymphoma diagnosis and treatment . The most commonly used radiotracer in PET imaging is F-18 fluorodeoxyglucose ( FDG ), a glucose analogue . FDG-PET scans have been very accurate than conventional imaging in evaluation of many malignancies . The other radionuclide used is Rubidium-82 .
PET imaging radioisotopes has got many applications in clinical neurology which involves movement disorders , epilepsy , brain tumors , dementia , Stroke and neuronal plasticity etc . Future applications include early diagnosis of brain metastases , Parkinson syndromes and neurodegenerative disorders such as AD . Market for radioisotopes is expected to be more in developing countries because of increasing awareness of people for radioisotopes , increasing incidence of chronic disease like cancer and increasing population .
Market is segmented by type of radioisotopes ( Technetium-99m ( TC-99m ), Thallium-201 ( TL-201 ), Iodine ( I-123 ), Fluorine-18 , Rubidium-82 ( RB-82 ) and others ). By application market is segmented into ( cardiology , lymphoma , thyroid , neurology oncology , and others ). By geography market is segmented into North America , Europe and Asia-Pacific etc .
Major players in the market GE Healthcare , Hologic Inc ., Medix Inc ., Naviscan Inc ., Positron Corporation , Segami Corporation . Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is a strategy adopted by multinational players .
Purchase a copy of Global Nuclear Medicine Radioisotopes Market visit @ http :// www . orbisresearch . com / contact / purchase / 219737 For more information contact sales @ orbisresearch . com . www . orbisresearch . com ; + 1 ( 214 ) 884-6817 ; + 9120-64101019